In relation to the contribution of the ETS1/TGM2 axis in the invasive properties of CRC and 5-Fu or cisplatin in inducing apoptosis, the ETS1/TGM2 axis was found to decrease early apoptosis and promote chemotherapy resistance (Fig. 5e). The gene discussed is ETS1; the disease is colorectal carcinoma.